The Delaney Collaboratory to Cure HIV - 1 Infection by Combination Immunotherapy (BEAT - HIV Collaboratory) is a consortium of more than 30 top HIV researchers from leading academic research institutions working with government, nonprofit organizations, and industry partners to test combinations of several novel immunotherapies under
new preclinical research and clinical trials.
New preclinical research on the molecular mechanisms responsible for sickle cell disease could aid efforts to develop much needed treatments for this devastating blood disorder that affects millions worldwide.
New preclinical research provides support to a drug that has been repurposed to possibly treat a rare and extremely disabling genetic bone disease, particularly in children.
Not exact matches
In
preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich's ataxia (FA), a widely used cholesterol - lowering drug increased a precursor of HDL (high - density lipoprotein), the «good cholesterol,» according to
new research published in PLOS ONE from the Perelman School of Medicine at the University of Pennsylvania.
«To better understand safety issues, we are making efforts to employ more modern investigational, molecular approaches to safety assessment — and increase our safety testing work force by about 10 percent,» says Phil Bentley, vice president and global head of
preclinical safety at Novartis Institutes for BioMedical
Research in
New York City.
In a paper published in Advanced Functional Materials, the
research team reports on the
new material's key properties, many of which can be finely tuned, and on the results of using the material in
preclinical models of wound healing.
According to the authors of the study, in future
researches it will be necessary to know about the action mechanism of the
new products - highly selective and with low cell toxicity on in vitro tests - and broaden
preclinical studies with laboratory animal models.
E. Intensify
research on the major drivers of childhood cancers Improve our understanding of fusion oncoproteins in pediatric cancer and use
new preclinical models to develop inhibitors that target them.
Janssen GPH will also prioritise work with the International Partnership for Microbicides developing the investigational drug dapivirine for use as a monthly vaginal microbicidal ring designed to prevent sexual transmission of HIV and continue its pact with Drugs for Neglected Diseases initiative for the
preclinical research of a reformulated form of flubendazole for lymphatic filariasis (elephantiasis) and onchocerciasis (river blindness), Janssen GPH is also developing a
new, chewable formulation of Vermox (mebendazole) that will facilitate treatment of intestinal worms in younger children.
37 experts, whose European speakers involved in INFRAFRONTIER Mouse clinics, will share with you all the
new approaches that will profoundly change the basic,
preclinical and biopharmaceuticals
researches.
Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced that
new preclinical data supporting the development of microbiome therapeutics for immuno - oncology (leveraging gut microbiota to impact tumor immunotherapy) 1 will be presented today by Sceneay et al in the late breaking poster session at the 2018 American Association for Cancer
Research Annual Meeting (AACR) in Chicago.
It enables scientists at Moderna's ventures and
New Venture Labs, as well as our biopharma partners, to digitally design and order mRNA constructs for use in discovery
research and
preclinical studies through an encrypted and secure portal.
As MD Anderson moves toward molecular characterization of the cancers of all our patients, allowing their optimal assignments to promising
new targeted therapies and potential identification of biomarkers of response and resistance, the department's mission includes thematic translational
research and
preclinical molecular pathology
research.
In an effort to further exploit the potential of Pexa - Vec to activate the immune system to fight cancer, as seen in McDonald's
preclinical data, SillaJen recently announced a
new clinical trial in collaboration with New York - based Regeneron Inc. to test Pexa - Vec and REGN2810, a PD - 1 checkpoint inhibitor, in combination against renal cell carcinoma, and recently signed a sponsored research agreement with UCSF to enable joint support of parallel preclinical experiments by McDonald's te
new clinical trial in collaboration with
New York - based Regeneron Inc. to test Pexa - Vec and REGN2810, a PD - 1 checkpoint inhibitor, in combination against renal cell carcinoma, and recently signed a sponsored research agreement with UCSF to enable joint support of parallel preclinical experiments by McDonald's te
New York - based Regeneron Inc. to test Pexa - Vec and REGN2810, a PD - 1 checkpoint inhibitor, in combination against renal cell carcinoma, and recently signed a sponsored
research agreement with UCSF to enable joint support of parallel
preclinical experiments by McDonald's team.
PHILADELPHIA — In
preclinical studies using cell models that mimicked liver cells of patients with the rare disease Friedreich's ataxia (FA), a widely used cholesterol - lowering drug increased a precursor of HDL (high - density lipoprotein), the «good cholesterol,» according to
new research published in PLOS One from the Perelman School of Medicine at the University of Pennsylvania.
The Department of Translational
Research hosts 5 technological platforms (Genomics, Protein arrays, High - content screening, Experimental radiotherapy and
Preclinical investigation), 4 labeled teams (resistance to therapy in breast cancers, translational pediatrics, angiogenesis, and immunotherapy) and 3 emergent teams (Circulating biomarkers, uveal melanoma, and
new targets in triple negative breast cancers).
New UC developments will contribute to the three categories of
research CIRM hopes to establish: basic stem cell
research and discovery,
preclinical and clinical
research, and
preclinical development; centers of excellence which will work with any duel combination of stem cell discovery, clinical
research and
preclinical development; and special programs which will work with specialized
research programs.
At Vets Plus, Dr. Ajay leads
new product development initiatives, overseeing all
preclinical and clinical trials and
research.